TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
出版年份 2021 全文链接
标题
TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
作者
关键词
TGF-β, Fibrosis, Therapeutic strategies
出版物
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 911, Issue -, Pages 174510
出版商
Elsevier BV
发表日期
2021-09-21
DOI
10.1016/j.ejphar.2021.174510
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells
- (2020) Cyril Corbet et al. Nature Communications
- TGF-β Signaling
- (2020) Kalliopi Tzavlaki et al. Biomolecules
- SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β Signaling
- (2020) Jinhang Zhang et al. MOLECULAR PHARMACEUTICS
- Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
- (2019) Davide Di Fusco et al. Frontiers in Pharmacology
- Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway
- (2019) Ying Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice
- (2018) Juanjuan Shou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants
- (2018) Charlotte H. Maden et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
- (2018) Joanne E. Murphy-Ullrich et al. MATRIX BIOLOGY
- Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling
- (2018) Xingli Ji et al. MEDICAL SCIENCE MONITOR
- The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling
- (2018) Petros Andrikopoulos et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors
- (2018) Hideki Terashima et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis
- (2017) Jiwei Hou et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
- (2017) Jonathan M. Yingling et al. Oncotarget
- First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
- (2017) Norbert Pfeiffer et al. PLoS One
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria
- (2016) Xiaoyan Liang et al. PLoS One
- Signaling Receptors for TGF-β Family Members
- (2016) Carl-Henrik Heldin et al. Cold Spring Harbor Perspectives in Biology
- TGF-β Signaling from Receptors to Smads
- (2016) Akiko Hata et al. Cold Spring Harbor Perspectives in Biology
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
- (2016) Masato Morikawa et al. Cold Spring Harbor Perspectives in Biology
- Blocking TGF-β expression inhibits silica particle-induced epithelial–mesenchymal transition in human lung epithelial cells
- (2015) Yi Rong et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
- (2015) Lisa M. Rice et al. JOURNAL OF CLINICAL INVESTIGATION
- Latent TGF-β-binding proteins
- (2015) Ian B. Robertson et al. MATRIX BIOLOGY
- Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis
- (2015) RHUN YIAN KOH et al. Molecular Medicine Reports
- Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels
- (2014) Tetsu Kobayashi et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling
- (2014) Sang-A Park et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
- (2014) Jordi Rodon et al. CLINICAL CANCER RESEARCH
- R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model
- (2014) Hideki Terashima et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1
- (2014) Yu-Chao Chang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent
- (2014) Cheng Hua Jin et al. JOURNAL OF MEDICINAL CHEMISTRY
- EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis
- (2014) J. Y. Son et al. MOLECULAR CANCER THERAPEUTICS
- Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2
- (2014) Bethany N. Smith et al. PLoS One
- Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling
- (2013) Andrea Conidi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition
- (2013) JAMES W. ANTOON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
- (2013) Hong Ling et al. PLoS One
- Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
- (2013) Francesco Dituri et al. PLoS One
- Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing
- (2013) Mohammadreza Pakyari et al. Advances in Wound Care
- Transforming Growth Factor β-1 Stimulates Profibrotic Epithelial Signaling to Activate Pericyte-Myofibroblast Transition in Obstructive Kidney Fibrosis
- (2012) Ching-Fang Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy
- (2012) Nicolas Hunzelmann et al. ARTHRITIS RESEARCH & THERAPY
- The transcription factor JunD mediates transforming growth factor -induced fibroblast activation and fibrosis in systemic sclerosis
- (2011) K. Palumbo et al. ANNALS OF THE RHEUMATIC DISEASES
- TGF-β signaling in fibrosis
- (2011) Anna Biernacka et al. GROWTH FACTORS
- Fibroblasts and myofibroblasts in renal fibrosis
- (2011) Soma Meran et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Latent TGF-β structure and activation
- (2011) Minlong Shi et al. NATURE
- Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model
- (2011) Noriyuki Sugiyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- Cross Talk among TGF- Signaling Pathways, Integrins, and the Extracellular Matrix
- (2011) J. S. Munger et al. Cold Spring Harbor Perspectives in Biology
- Adenovirus-Mediated Decorin Gene Transfection Has Therapeutic Effects in a Streptozocin-Induced Diabetic Rat Model
- (2010) Zhe Zhang et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis
- (2009) Nicole Reich et al. ARTHRITIS AND RHEUMATISM
- Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
- (2009) Shreyas Das et al. BMC CELL BIOLOGY
- Transforming Growth Factor-βs and Mammary Gland Involution; Functional Roles and Implications for Cancer Progression
- (2009) Kathleen C. Flanders et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression
- (2008) Eleonora Patsenker et al. GASTROENTEROLOGY
- Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
- (2008) Yury Popov et al. JOURNAL OF HEPATOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
- (2007) Lorea Bueno et al. EUROPEAN JOURNAL OF CANCER
- Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
- (2007) M. Petersen et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More